APA

Darb-Esfahani S., Kronenwett R., von Minckwitz G., Denkert C., Gehrmann M., Rody A., Budczies J., Brase J. C., Mehta M. K., Bojar H., Ataseven B., Karn T., Weiss E., Zahm D. M., Khandan F., Dietel M. & Loibl S. (20130307). Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer. : British journal of cancer.

Chicago

Darb-Esfahani S, Kronenwett R, von Minckwitz G, Denkert C, Gehrmann M, Rody A, Budczies J, Brase J C, Mehta M K, Bojar H, Ataseven B, Karn T, Weiss E, Zahm D M, Khandan F, Dietel M and Loibl S. 20130307. Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer. : British journal of cancer.

Harvard

Darb-Esfahani S., Kronenwett R., von Minckwitz G., Denkert C., Gehrmann M., Rody A., Budczies J., Brase J. C., Mehta M. K., Bojar H., Ataseven B., Karn T., Weiss E., Zahm D. M., Khandan F., Dietel M. and Loibl S. (20130307). Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer. : British journal of cancer.

MLA

Darb-Esfahani S, Kronenwett R, von Minckwitz G, Denkert C, Gehrmann M, Rody A, Budczies J, Brase J C, Mehta M K, Bojar H, Ataseven B, Karn T, Weiss E, Zahm D M, Khandan F, Dietel M and Loibl S. Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer. : British journal of cancer. 20130307.